FILE - This Friday, Oct. 10, 2008, file photo illustration shows Johnson & Johnson products, in Philadelphia. In a deal announced Thursday, Jan. 26, 2017, Johnson & Johnson is buying Swiss pharmaceutical Actelion in a $30 billion deal that will boost its treatments for life-threatening high blood pressure conditions. (AP Photo/Matt Rourke, File)
Southern California wildfire destroys 132 structures as officials look for fierce winds to subside Shares
Ovechkin scoring another game-winning goal for the Capitals comes as no surprise to the Predators Shares
4 astronauts return to Earth after being delayed by Boeing's capsule trouble and Hurricane Milton Shares